Season 1

Exploring Treating Covid 19 Through Cell Signalling

In this interview Dr. Lorne Brown and Dr. John McMichaels speak about the clinical studies on COVID-19 with a new product called TML. It is a viral product built to work with cells signaling. TML works in a way that brings the body back into balance providing all the bodies mechanisms are there and available at the cellular level.

This product is not a cure but meant to catch the disease early so a person does not end up in the hospital.

 

  Highlights

 

Start – Dr. John McMichael introduction

2:31 mins – Discussing clinical trial for COVID-19

4:00 mins – Discussing cell signalling and explaining how it works

6:17 mins – How resonant molecular signalling impacts disease and health

8:21 mins – Discussing being able to help ‘long haulers’

9:45 mins – Discussing severe reactions and being hospitalized

10:12 mins- Discussing TML with recurrent oral herpes infections

11:38 mins – Discussing other products in the works

12:53 mins- Discussing the mechanism for brain injury

15:00 mins – Discussing the mechanisms for anxiety and depression and creating the product

16:35 mins – Discussing micro-dosing and hormesis

19:18 mins – Discussing the success rate with the TML

20:09 mins – Discussing why it doesn’t work for everyone

22:05 mins – Discussing Phase 3 with TML and when it should be expected

24:28 mins – Mentioning beechtreelabs.com donations and investing

25:00 mins – Discussing continued research on anxiety and depression TML

25:14 mins – Discussing the material in products used and safety issues

29:11 mins – Discussing if you can take the product prophetically

30:08 mins – Closing off the interview with Dr. John McMichael

 

 

 

 

 

 

 

 

 

 

 

Hosts & Guests

Lorne Brown

John McMichael

Share Episode

Facebook

LinkedIn

Twitter 

About the Speaker

John McMichael, Ph.D., President & CEO

Dr. McMichael received his B.S. in Microbiology from the University of Maine and his Ph.D. from Oregon State University in Immunology and Virology, and did his post-doctoral work at the Wistar Institute in Philadelphia, PA. He developed the world’s first live-virus fish vaccines for use in fish populations, and is an Alzheimer’s disease pioneer, having licensed 30+ patents to Elan Corp. plc, to support their Alzheimer’s initiative. He now holds more than 200 patents worldwide. His experience also includes:

  • Professor of Biology and Health Sciences, Edinboro University of Pennsylvania;
  • General Manager for ImmunoTherapeutics, where he licensed a veterinary anti-inflammatory product to Eudomonics, Inc., which launched and continues to sell the product;
  • Vice President of Molecular Rx, Inc., a biopharmaceutical company focused on products for managing inflammatory responses;
  • Founder and President of Milkhaus Laboratory, Inc., a company now focused on botanical agents for nutraceutical use;
  • Founder and President of The Institute for Therapeutic Discovery, a not-for-profit organization focusing on the interplay between biochemistry and biophysics in the course and management of health and disease.

Don’t Miss Another Conscious Talk!

Get the latest interviews right in your inbox.


Select your currency
USD United States (US) dollar